DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Xenon Pharmaceuticals FY19 EPS $(1.54) Up From $(1.63) In FY18, Sales $6.829M

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.54) per share. This is a 5.52 percent increase over losses of $(1.63) per share from the same period last year. The company reported $6.829 million in

Benzinga · 03/09/2020 20:02

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.54) per share. This is a 5.52 percent increase over losses of $(1.63) per share from the same period last year. The company reported $6.829 million in sales this quarter.